Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mercaptopurine (oral liquid)

EU orphan designation number: EU/3/07/496   
Active ingredient: Mercaptopurine (oral liquid)
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Orbona Pharma Ltd
Old Chambers, 93-94 West Street, Farnham, Surrey GU97EB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2007 Centralised Orphan - Designation EMEA/OD/065/07 (2007)5242 of 22/10/2007
04/10/2013 Other procedure
04/11/2013 Centralised Orphan - Transfer of orphan designation EMEA/OD/065/07/T/01 (2013)7463 of 30/10/2013